Skip to content
value.today

Otonomy vs Vaxart, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Otonomy and Vaxart, Inc. are worth about the same: $113 M and $117 M (market caps of Jan 7, 2022 for Otonomy and Oct 22, 2026 for Vaxart, Inc.). Otonomy's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
  • Vaxart, Inc. had more revenue: $237 M in the year to December 2025 against $0 M for Otonomy in the year to December 2020.
  • Vaxart, Inc. made a net profit of $16 M, while Otonomy made a net loss of $45 M.
  • Vaxart, Inc. keeps more of each dollar of sales: a net margin of 6.9% against -16555.6% for Otonomy.

Market value, the same start = 100

From Jan 2022: how each one's value moved, whatever its size.

02550751002023202420252026Vaxart, Inc. 15

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Vaxart, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureOtonomy
OTIC
Vaxart, Inc.
VXRT · #18,166 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded20082004
Size
Market cap$113 M*$117 M
Revenue$0 M$237 M
Net income$-45 M$16 M▲ best
Employees—15
Valuation
P/E ratio—4.0×
Price to sales—0.7×
Price to book—1.3×
Free cash flow yield—6.5%
Profitability
Operating margin—7.6%
Net margin—6.9%
Return on equity—22.3%
Growth
Revenue growth—726.7%
Cash
Free cash flow margin—3.2%
Altman Z-score zone—distress
Data as ofMarket cap Jan 2022Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Otonomy or Vaxart, Inc.?

Otonomy and Vaxart, Inc. are worth about the same: $113 M and $117 M (market caps of Jan 7, 2022 for Otonomy and Oct 22, 2026 for Vaxart, Inc.). Otonomy's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, Otonomy or Vaxart, Inc.?

Vaxart, Inc. had more revenue: $237 M in the year to December 2025 against $0 M for Otonomy in the year to December 2020. Vaxart, Inc. made a net profit of $16 M, while Otonomy made a net loss of $45 M.

Which is more profitable, Otonomy or Vaxart, Inc.?

Vaxart, Inc. keeps more of each dollar of sales: a net margin of 6.9% against -16555.6% for Otonomy.